Parental attitudes toward new dosage forms of desloratadine in an online survey: results from four European countries

References

• Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 2006;368:733-43
   PubMed Web of Science ®Google Scholar
• Bousquet J, Ansotegui IJ, van Ree R, et al. European Union meets the challenge of the growing importance of allergy and asthma in Europe. Allergy 2004;59:1-4
   PubMed Web of Science ®Google Scholar
• Kakumanu S, Glass C, Craig T. Poor sleep and daytime somnolence in allergic rhinitis: significance of nasal congestion. Am J Respir Med 2002;1:195-200
   PubMedGoogle Scholar
• Urschitz M, Guenther A, Eggebrecht E, et al. Snoring, intermittent hypoxia and academic performance in primary school children. Am J Respir Crit Care Med 2003;168:464-8
   PubMed Web of Science ®Google Scholar
• Blaiss MS. Allergic rhinitis and impairment issues in schoolchildren: a consensus report. Curr Med Res Opin 2004;2:1937-52
   Google Scholar
• O’Donnell BF, Lawlor F, Simpson J, et al. Chronic urticaria: impact on quality of life. Br J Dermatol 1997;136:197-201
   PubMed Web of Science ®Google Scholar
• Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108(Suppl.):S45-53
   PubMedGoogle Scholar
• Walker S, Khan-Wasti S, Fletcher M, et al. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case–control study. J Allergy Clin Immunol 2007;120:381-7
   PubMed Web of Science ®Google Scholar
• Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl. 86):8-160
   PubMed Web of Science ®Google Scholar
• Scadding GK, Durham SR, Mirakian R, et al. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy 2008;38:19-42
   PubMed Web of Science ®Google Scholar
• Zuberbier T, Bindslev-Jensen C, Canonica W, et al. EAACI/GA2LEN/EDF guideline: management of urticaria. Allergy 2006;61:321-31
   PubMed Web of Science ®Google Scholar
• Canonica GW, Bousquet J, Mullol J, et al. A survey of the burden of allergic rhinitis in Europe. Allergy 2007;62(Suppl. 85):17-25
   PubMed Web of Science ®Google Scholar
• Keith PK, Luciuk G. Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: results of a Canadian multicenter, open-label trial. Clin Ther 2007;29:419-26
   PubMed Web of Science ®Google Scholar
• Kim K, Sussman G, Hebert J, et al. Desloratadine therapy for symptoms associated with perennial allergic rhinitis. Ann Allergy Asthma Immunol 2006;96:460-5
   PubMed Web of Science ®Google Scholar
• Haye R, Hoye K, Berg O, et al. Morning versus evening dosing of desloratadine in seasonal allergic rhinitis: a randomized controlled study [ISRCTN23032971]. Clin Mol Allergy 2005;3:3
   PubMedGoogle Scholar
• Bousquet J, Bindslev-Jensen C, Canonica GW, et al. The ARIA/EAACI criteria for antihistamines: an assessment of the efficacy, safety and pharmacology of desloratadine. Allergy 2004;59(Suppl. 77):4-16
   PubMed Web of Science ®Google Scholar
• Simons FE, Prenner BM, Finn Jr A, for the Desloratadine Study Group. Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol 2003;111:617-22
   PubMed Web of Science ®Google Scholar
• Berger WE, Schenkel EJ, Mansfield LE, for the Desloratadine Study Group. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion. Ann Allergy Asthma Immunol 2002;89:485-91
   PubMed Web of Science ®Google Scholar
• Ortonne JP, Grob JJ, Auquier P, et al. Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial. Am J Clin Dermatol 2007;8:37-42
   PubMed Web of Science ®Google Scholar
• Monroe E, Finn A, Patel P, et al. Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol 2003;48:535-41
   PubMed Web of Science ®Google Scholar
• Ring J, Hein R, Gauger A et al, and the Desloratadine Study Group. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Int J Dermatol 2001;40:72-6
   PubMed Web of Science ®Google Scholar
• Prenner B, Ballona R, Bueso A, et al. Safety of desloratadine syrup in children six months younger than 2 years of age: a randomized, double-blinded, placebo-controlled study. Ped Asthma Allergy Immunol 2006;19:91-9
   Google Scholar
• Rossi GA, Tosca MA, Passalacqua G, et al. Evidence of desloratadine syrup efficacy and tolerability in children with pollen-induced allergic rhinitis. Allergy 2005;60:416-17
   PubMed Web of Science ®Google Scholar
• Bloom M, Staudinger H, Herron J. Safety of desloratadine syrup in children. Curr Med Res Opin 2004;20:1959-65
   PubMed Web of Science ®Google Scholar
• Roberts KR, Linder L, Sund ML. Glucose incorporation by human dental plaque bacteria. Caries Res 1981;15:492-500
   PubMed Web of Science ®Google Scholar
• Maguire A, Rugg-Gunn AJ. Changes in the prescribing of liquid oral medicines (LOMs) in the northern region of England between 1987 and 1992 with special regard to sugar content and long-term use in children. Community Dent Health 1997;14:31-5
   PubMedGoogle Scholar
• Shaw L, Glenwright HD. The role of medications in dental caries formation: need for sugar-free medication for children. Pediatrician 1989;16:153-5
   PubMedGoogle Scholar
• Department of Health, Report on Health & Social Subjects No 37 Dietary Sugars and Human Disease. Report of the Panel on Dietary Sugars, Committee on Medical Aspects of Food Policy. London: HSMO, 1989
   Google Scholar
• American Dental Association Position Statement. Role of sugar-free foods and medications in maintaining good oral health. November 1, 1999. Available at: http://www.ada.org/prof/resources/positions/statements/sugarfre.asp [Last accessed 3 June 2009]
   Google Scholar
• American Academy of Pediatrics Committee on Drugs. ‘Inactive’ ingredients in pharmaceutical products: update (subject review). Pediatrics 1997;99:268-78
   PubMed Web of Science ®Google Scholar
• European Commission. Guidelines, Volume 3B – Medicinal Products for Human Use. Excipients in the label and package leaflet of medicinal products for human use. July 2003
   Google Scholar
• Bogner RH, Wilkosz MF. Fast-dissolving tablets. US Pharma 2002. Available at: http://www.uspharmacist.com/oldformat.asp?url=newlook/files/feat/fastdissolving.htm [Last accessed 29 April 2009]
   Google Scholar
• Hunter ML, Lewis R, Hunter B. Consumer demand in the purchase and prescription of sugar-free medicines. Int J Paediatr Dent 2000;10:140-4
   PubMedGoogle Scholar
• Blaiss M, Skoner D, Iezzoni D, et al. Palatability of desloratadine 2.5-mg dissolvable tablets vs cetirizine 5-mg chewable tablets in children 6 to 11 years of age. Presented at: American College of Allergy, Asthma, and Immunology; Philadelphia, PA; November 10–15, 2006 [Poster P236]
   Google Scholar
• Pierro VS, Abdelnur JP, Maia LC, et al. Free sugar concentration and pH of paediatric medicines in Brazil. Community Dent Health 2005;22:180-3
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. FDA releases recommendations regarding use of over-the-counter cough and cold products: products should not be used in children under 2 years of age; evaluation continues in older populations [FDA news release]. Rockville, MD: Center for Drug Evaluation and Research, January 17, 2008. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116839.htm [Last accessed 3 June 2009]
   Google Scholar
• Statement from CHPA on the Voluntary Label Updates to Oral OTC Children's Cough and Cold Medicines [press release]. Washington, DC: Consumer Healthcare Products Association, October 7, 2008. Available at: http://www.chpa-info.org/10_07_08_PedCC.aspx [Last accessed 28 April 2009]
   Google Scholar